Cite
HARVARD Citation
Lamb, C. et al. (n.d.). P401 Risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications: Reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study. Journal of Crohn's and colitis. pp. S409-S410. [Online].